## Core Concept
Apparent mineralocorticoid excess (AME) is a rare genetic disorder characterized by hypertension, hypokalemia, and low plasma renin activity due to the overactivity of the mineralocorticoid receptor. This condition arises from the impaired conversion of cortisol to cortisone, leading to increased levels of cortisol that activate the mineralocorticoid receptor.

## Why the Correct Answer is Right
The correct answer, **11β-Hydroxysteroid Dehydrogenase Type 2 (11β-HSD2) deficiency**, is the underlying cause of apparent mineralocorticoid excess. 11β-HSD2 is an enzyme responsible for converting cortisol to cortisone in the kidney. Cortisone has a low affinity for the mineralocorticoid receptor, whereas cortisol has a high affinity. In the absence or deficiency of 11β-HSD2, cortisol is not adequately converted to cortisone, resulting in increased cortisol levels that bind to and activate the mineralocorticoid receptor, mimicking the effects of aldosterone.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not specify the correct enzyme or mechanism related to AME.
- **Option B:** This option is incorrect as it refers to a different condition or mechanism not directly related to the pathogenesis of AME.
- **Option C:** This option is incorrect because it does not accurately describe the cause of apparent mineralocorticoid excess.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that patients with apparent mineralocorticoid excess present with hypertension and hypokalemia, similar to primary aldosteronism, but the condition is caused by the abnormality in cortisol metabolism rather than an excess of aldosterone. This condition is extremely rare and often presents in infancy or early childhood.

## Correct Answer: D. 11β-Hydroxysteroid Dehydrogenase Type 2 deficiency.